BELITE

BELITE

Belite Study

Phase 1/2, open label, dose-finding followed by a 2-year extension study to evaluate the safety and tolerability of Tinlarebant in adolescent subjects with Stargardt Disease.

Principal Investigator – Dr. Fred Chen

Trial ANZCTR Registry Number: ACTRN12621000549820

For further information contact the Clinical Trials Office on (08) 9381 0750 or email clinicalresearch@lei.org.au

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment